Published in Am J Pathol on November 01, 1976
Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activation. Immunology (1979) 1.16
A protective role for the fifth complement component (c5) in allergic airway disease. Am J Respir Crit Care Med (2006) 1.09
The human eosinophil: roles in host defense and tissue injury. Am J Pathol (1980) 1.07
Human eosinophils and parasitic diseases: light and electron microscopy evidence of interaction with sheep erythrocyte. Clin Exp Immunol (1980) 0.89
Lung injury mediated by antibodies to endothelium. II. Study of the effect of repeated antigen-antibody interactions in rabbits tolerant to heterologous antibody. Am J Pathol (1987) 0.86
Hepatic eosinophil granulocytopoiesis in murine experimental Schistosomiasis mansoni. Br J Exp Pathol (1981) 0.80
Low zone desensitization: a stimulus-specific control mechanism of cell response. Investigations on anaphylatoxin-induced platelet secretion. J Exp Med (1982) 0.77
The management of hay fever in general practice. J R Coll Gen Pract (1979) 0.75
Differential regulation of C5a receptor 1 in innate immune cells during the allergic asthma effector phase. PLoS One (2017) 0.75
The C5a/C5aR1 axis controls the development of experimental allergic asthma independent of LysM-expressing pulmonary immune cells. PLoS One (2017) 0.75
Chemistry and reaction mechanisms of complement. Adv Immunol (1968) 5.02
A plasmin-split fragment of C'3 as a new chemotactic factor. J Exp Med (1967) 4.94
The sulphatase of ox liver. I. The complex nature of the enzyme. Biochem J (1953) 4.81
The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase. J Exp Med (1968) 4.79
A neutrophil chemotactic factor from human C'5. J Immunol (1969) 4.46
Eosinophilic gastroenteritis. Medicine (Baltimore) (1970) 4.00
A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein. J Exp Med (1972) 3.93
A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization. J Exp Med (1972) 3.75
C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J Immunol (1970) 3.75
Assay of sulfatases. Methods Biochem Anal (1957) 3.55
Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J Clin Invest (1970) 3.55
The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung. J Immunol (1971) 3.51
The assay of arylsulphatases A and B in human urine. Clin Chim Acta (1959) 3.47
Polymorphonulcear leukocyte chemotaxis toward oxidized lipid components of cell membranes. J Exp Med (1975) 2.91
Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors. J Clin Invest (1974) 2.90
Biogenesis of chemotactic molecules by the arachidonate lipoxygenase system of platelets. Nature (1975) 2.84
Inactivation of slow reacting substance of anaphylaxis by human eosinophil arylsulfatase. J Immunol (1975) 2.73
An eosinophil leukocyte chemotactic factor of anaphylaxis. J Exp Med (1971) 2.65
The function of the eosinophile leukocyte. Blood (1953) 2.59
Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis. Proc Natl Acad Sci U S A (1975) 2.56
Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator. J Exp Med (1973) 2.50
The selective eosinophil chemotactic activity of histamine. J Exp Med (1975) 2.45
Tumor-associated eosinophilotactic factor. N Engl J Med (1974) 2.27
Studies on eosinophil leucocyte migration. I. Eosinophil and neutrophil accumulation following antigen-antibody reactions in guinea-pig skin. Clin Exp Immunol (1970) 2.13
Biochemical demonstration of the activatable esterase of the rabbit netrophil involved in the chemotactic response. J Immunol (1970) 2.12
Chemotactic factor inactivator in normal human serum. J Clin Invest (1973) 1.93
The release of four mediators of immediate hypersensitivity from human leukemic basophils. J Immunol (1975) 1.92
Eosinophils and immune mechanisms. Eosinophil stimulation promoter (ESP): a lymphokine induced by specific antigen or phytohemagglutinin. J Immunol (1973) 1.89
Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid. J Clin Invest (1974) 1.81
Chemotactic deactivation of human eosinophils by the eosinophil chemotactic factor of anaphylaxis (38527). Proc Soc Exp Biol Med (1975) 1.68
A neutrophil immobilizing factor derived from human leukocytes. II. Specificity of action on polymorphonuclear leukocyte mobility. J Immunol (1973) 1.45
Mechanism of eosinophilia. V. Kinetics of normal and accelerated eosinopoiesis. Cell Tissue Kinet (1971) 1.42
Immunologic release of chemical mediators from human nasal polyps. N Engl J Med (1973) 1.42
The complement system of man. 3. N Engl J Med (1972) 1.41
Tropical eosinophilic syndrome. A clinical description of the disorder as seen in S. Rhodesia. Cent Afr J Med (1959) 1.39
Plasma and cell-derived inhibitors of human neutrophil chemotaxis. Ann N Y Acad Sci (1975) 1.32
Quantitative study of the eosinophil granulocytes. Semin Hematol (1968) 1.23
Antihistaminic effect of eosinophil leukocytes. Experientia (1950) 1.21
The eosinophilic response in the horse to intramedullary and intradermal injections of histamine, ACTH, and cortisone. J Pathol Bacteriol (1956) 1.15
Investigations on eosinophilia. The influence of histamine, antigen-antibody complexes containing gamma-1 or gamma-2 globulins, foreign bodies (phagocytosis) and disrupted mast cells. Br J Dermatol (1970) 1.14
The sulphatase of ox liver. XI. The isoelectric focussing of a purified preparation of sulphatase B. Biochim Biophys Acta (1968) 1.13
Isolation of human eosinophil phospholipase D. J Clin Invest (1976) 1.11
The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator. J Clin Invest (1973) 1.10
Selective attraction of eosinophils and synergism between eosinophil chemotactic factor of anaphylaxis (ECF-A) and a fragment cleaved from the fifth component of complement (C5a). Immunology (1973) 1.07
Lymphocyte-derived eosinophil chemotactic factor. II. Studies on the mechanism of activation of the precursor substance by immune complexes. J Immunol (1973) 1.00
The physiological role of gamma-globulin. Adv Enzymol Relat Areas Mol Biol (1974) 0.98
The characteristics, isolation and synthesis of the phagocytosis stimulating peptide tuftsin. Biochem Biophys Res Commun (1972) 0.96
STUDIES IN EXPERIMENTAL EOSINOPHILIA. 7. EOSINOPHILS IN LYMPH NODES DURING THE FIRST 24 HR FOLLOWING PRIMARY ANTIGENIC STIMULATION. J Immunol (1964) 0.95
Chemotactic activity derived from interaction of factors D and B of the properdin pathway with cobra venom factor or C3B. J Clin Invest (1975) 0.94
Experimental eosinophilia. IV. Eosinotactic influences of polysaccharides. Exp Mol Pathol (1963) 0.92
Complement-derived leukotactic factors in pathological fluids. J Exp Med (1971) 0.91
Eosinophil chemotaxis of supernatants from cultured Hodgkin's lymph node cells. J Clin Pathol (1975) 0.90
Macrophage-eosinophil interactions in the inflammatory response to Trichinella spiralis. Blood (1974) 0.89
Antihistamine activity in extracts of horse eosinophils. Br J Pharmacol Chemother (1962) 0.89
Modulation of the immunological release of the eosinophil chemotactic factor of anaphylaxis from human lung. Immunology (1974) 0.88
Kinetic properties of three soluble arylsulphatases from ox brain, homogeneous in polyacrylamide gel electrophoresis. Enzymologia (1969) 0.82
Eosinophilia in children. Pediatr Clin North Am (1972) 0.81
Eosinophil leucocyte-attracting effect of histamine in the sheep skin. Indian J Exp Biol (1972) 0.79
Studies of immediate hypersensitivity in a patient with Acanthocheilonema perstans filarial infection. J Infect Dis (1975) 0.76
A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization. J Exp Med (1972) 3.75
Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid. J Clin Invest (1977) 3.10
The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs). J Immunol (1980) 2.93
Affinity labeling of a mouse myeloma protein which binds nitrophenyl ligands. Kinetics of labeling and isolation of a labeled peptide. Biochemistry (1970) 2.88
Inactivation of slow reacting substance of anaphylaxis by human eosinophil arylsulfatase. J Immunol (1975) 2.73
Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis. Proc Natl Acad Sci U S A (1975) 2.56
Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J Biol Chem (1998) 2.49
Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis. J Clin Invest (1980) 2.37
Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. J Natl Cancer Inst (2001) 2.27
Tumor-associated eosinophilotactic factor. N Engl J Med (1974) 2.27
Generation of unique mono-hydroxy-eicosatetraenoic acids from arachidonic acid by human neutrophils. J Exp Med (1979) 2.20
O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J Appl Physiol (1985) (1986) 2.16
Characteristics of the cofactor requirements for the superoxide-generating NADPH oxidase of human polymorphonuclear leukocytes. Biochemistry (1981) 2.11
Novel structural determinants of the human neutrophil chemotactic activity of leukotriene B. J Exp Med (1981) 2.09
Molecular and cellular mechanisms of leukocyte chemotaxis. Science (1981) 2.07
Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4. Identification of a subset of high affinity receptors that transduce the chemotactic response. J Exp Med (1984) 2.03
Chemotactic and chemokinetic stimulation of human eosinophil and neutrophil polymorphonuclear leukocytes by 12-L-hydroxy-5,8,10-heptadecatrienoic acid (HHT). J Immunol (1978) 2.02
The release of four mediators of immediate hypersensitivity from human leukemic basophils. J Immunol (1975) 1.92
Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products. Clin Exp Immunol (1982) 1.84
Mediators of immediate hypersensitivity derived from arachidonic acid. N Engl J Med (1980) 1.83
Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid. J Clin Invest (1974) 1.81
Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes. J Immunol (1982) 1.80
Cyclophosphamide in lupus nephritis: a controlled trial. Ann Intern Med (1971) 1.70
Specific stimulation of human T lymphocytes by substance P. J Immunol (1983) 1.65
Respiratory gases of synovial fluids. An approach to synovial tissue circulatory-metabolic imbalance in rheumatoid arthritis. Am J Med (1970) 1.65
Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system. Neuroscience (1989) 1.62
Leukotriene and prostaglandin sensitization of cutaneous high-threshold C- and A-delta mechanonociceptors in the hairy skin of rat hindlimbs. Neuroscience (1987) 1.62
Structural determinants of the eosinophil: chemotactic activity of the acidic tetrapeptides of eosinophil chemotactic factor of anaphylaxis. J Exp Med (1976) 1.61
Modulation of human neutrophil function by monohydroxy-eicosatetraenoic acids. Immunology (1980) 1.60
Predominant generation of 15-lipoxygenase metabolites of arachidonic acid by epithelial cells from human trachea. Proc Natl Acad Sci U S A (1985) 1.59
Identification of cDNAs encoding two G protein-coupled receptors for lysosphingolipids. FEBS Lett (1997) 1.57
Pertussis toxin inhibition of chemotactic factor-induced calcium mobilization and function in human polymorphonuclear leukocytes. J Exp Med (1985) 1.54
Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. Science (1984) 1.53
Modulation of human neutrophil polymorphonuclear leucocyte migration by human plasma alpha-globulin inhibitors and synthetic esterase inhibitors. Immunology (1975) 1.52
Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid. Biochem Biophys Res Commun (1983) 1.51
Novel effects of 1-O-hexadecyl-2-acyl-sn-glycero-3-phosphorycholine mediators on human leukocyte function: delineation of the specific roles of the acyl substituents. Biochem Biophys Res Commun (1980) 1.50
A neutrophil immobilizing factor derived from human leukocytes. II. Specificity of action on polymorphonuclear leukocyte mobility. J Immunol (1973) 1.45
Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid. Biochem Biophys Res Commun (1997) 1.45
The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. J Mol Cell Cardiol (2001) 1.44
Immunologic components of hypersensitivity reactions to cromolyn sodium. N Engl J Med (1975) 1.42
Chemotactic factor receptors of human PMN leucocytes. I. Effects on migration of labelling plasma membrane determinants with impermeant covalent reagents and inhibition of labelling by chemotactic factors. Immunology (1979) 1.42
Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. Am J Physiol Cell Physiol (2000) 1.42
Structural and catalytic properties of the solubilized superoxide-generating activity of human polymorphonuclear leukocytes. Solubilization, stabilization in solution, and partial characterization. Biochemistry (1979) 1.41
Preformed eosinophil chemotactic factor of anaphylaxis (ECF-A). J Immunol (1974) 1.40
Functional characterization of synthetic leukotriene B and its stereochemical isomers. J Exp Med (1981) 1.37
Neuroimmunology. Adv Immunol (1986) 1.37
The regulation of human eosinophil function by endogenous mono-hydroxy-eicosatetraenoic acids (HETEs). J Immunol (1980) 1.36
"Streaking leukocyte factor," arthritis, and pyoderma gangrenosum. Pediatrics (1975) 1.35
Cloning and expression of the human vasoactive intestinal peptide receptor. Proc Natl Acad Sci U S A (1991) 1.34
Specific binding of phospholipid platelet-activating factor by human platelets. J Immunol (1982) 1.33
Specific inhibition of the polymorphonuclear leukocyte chemotactic response to hydroxy-fatty acid metabolites of arachidonic acid by methyl ester derivatives. J Clin Invest (1979) 1.32
Plasma and cell-derived inhibitors of human neutrophil chemotaxis. Ann N Y Acad Sci (1975) 1.32
Substance P recognition by a subset of human T lymphocytes. J Clin Invest (1984) 1.31
Cyclophosphamide: use in practice. Ann Intern Med (1974) 1.31
Quality of diagnostic examinations in a university hospital outpatient clinic. Ann Intern Med (1973) 1.30
Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals. Proc Natl Acad Sci U S A (1980) 1.30
Selective feed-back inhibition of the 5-lipoxygenation of arachidonic acid in human T-lymphocytes. Biochem Biophys Res Commun (1981) 1.28
Alveolar macrophage lipoxygenase products of arachidonic acid: isolation and recognition as the predominant constituents of the neutrophil chemotactic activity elaborated by alveolar macrophages. Cell Immunol (1980) 1.28
A neutrophil-dependent pathway for the generation of a neutral peptide mediator: partial characterization of components and control by alpha-1-antitrypsin. J Exp Med (1974) 1.26
Selective generation of leukotriene B4 by tracheal epithelial cells from dogs. Biochem Biophys Res Commun (1983) 1.26
Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung. J Clin Invest (1978) 1.26
Specific binding by human polymorphonuclear leucocytes of the immunological mediator 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphorylcholine. Immunology (1983) 1.24
Isoforms of the EP3 subtype of human prostaglandin E2 receptor transduce both intracellular calcium and cAMP signals. Biochemistry (1994) 1.20
Platelet-derived growth factor stimulates mouse 3T3 cell mitogenesis and leukocyte chemotaxis through different structural determinants. J Clin Invest (1983) 1.19
Constituents of human neutrophils that mediate enhanced adherence to surfaces: purification and identification as acidic proteins of the specific granules. J Clin Invest (1980) 1.19
Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. Proc Natl Acad Sci U S A (1995) 1.18
A method for assessing the in vitro chemotactic response of neutrophils utilizing 51cr-labeled human leukocytes. Immunol Commun (1972) 1.18
Affinity labeling of a mouse myeloma protein which binds nitrophenyl ligands. Sequence and position of a labeled tryptic peptide. Biochemistry (1970) 1.17
Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis. N Engl J Med (1981) 1.17
Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid. N Engl J Med (1978) 1.16
Elevated concentrations of leukotriene D4 in pulmonary edema fluid of patients with the adult respiratory distress syndrome. J Clin Immunol (1984) 1.16
Eosinophil polymorphonuclear leukocyte function in immediate hypersensitivity. Arch Pathol (1975) 1.15
Defective human mononuclear leukocyte chemotaxis as an index of host resistance to malignant melanoma. Clin Immunol Immunopathol (1976) 1.15
Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor. FASEB J (2001) 1.14
The regulatory and effector roles of eosinophils. Adv Immunol (1979) 1.14
Enhancement of human neutrophil adherence by synthetic leukotriene constituents of the slow-reacting substance of anaphylaxis. Immunology (1983) 1.14
Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization. Mol Pharmacol (1998) 1.12
Stereospecific receptors for substance P on cultured human IM-9 lymphoblasts. J Immunol (1984) 1.12
Enhancement of neutrophil- and eosinophil-mediated complement-dependent killing of schistosomula of Schistosoma mansoni in vitro by leukotriene B4. Clin Exp Immunol (1983) 1.11
Contribution of the nervous system to the pathophysiology of rheumatoid arthritis and other polyarthritides. Rheum Dis Clin North Am (1987) 1.11
Leukotriene B4 and phosphatidic acid are calcium ionophores. Studies employing arsenazo III in liposomes. J Biol Chem (1982) 1.11
Isolation of human eosinophil phospholipase D. J Clin Invest (1976) 1.11
Isolation of two polypeptides comprising the neutrophil-immobilizing factor of human leucocytes. Immunology (1983) 1.10
The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator. J Clin Invest (1973) 1.10
Mono- and dihydroxyeicosatetraenoic acids alter calcium homeostasis in rabbit neutrophils. J Clin Invest (1981) 1.10
Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate. J Cell Biochem Suppl (1998) 1.10
A physiological approach to the assessment of disease activity in rheumatoid arthritis. J Clin Invest (1971) 1.10
A role for endogenous mono-hydroxy-eicosatetraenoic acids (HETEs) in the regulation of human neutrophil migration. Immunology (1980) 1.10
Active site chemotactic factors and the regulation of the human neutrophil chemotactic response. Antibiot Chemother (1971) (1974) 1.09
Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts. Cell Immunol (1984) 1.08
A sensitive and specific radioimmunoassay for leukotriene C4. FEBS Lett (1983) 1.08
Effects of intra-articular corticosteroids in vivo on synovial fluid variables in rheumatoid synovitis. Ann Rheum Dis (1974) 1.08
Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B4. Proc Natl Acad Sci U S A (1984) 1.07
The human eosinophil: roles in host defense and tissue injury. Am J Pathol (1980) 1.07
The immunological generation of a platelet-activating factor and a platet-lytic factor in the rat. Immunology (1979) 1.07
The conversion of leukotriene C4 to isomers of leukotriene B4 by human eosinophil peroxidase. Biochem Biophys Res Commun (1982) 1.06
Neuropeptide regulation of the expression of immediate hypersensitivity. J Immunol (1985) 1.05
Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid. J Clin Immunol (1986) 1.05
Selective localization of vasoactive intestinal peptide and substance P in human eosinophils. Biochem Biophys Res Commun (1987) 1.05
Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J Immunol (1996) 1.05